(Q47887279)

6 February 2018

title

Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma (English)

1 reference

6 February 2018

1 reference

Mónica Ricote

1

1 reference

6 February 2018

Ignacio García-Tuñón

2

1 reference

6 February 2018

Fermín R Bethencourt

3

1 reference

6 February 2018

Benito Fraile

4

1 reference

6 February 2018

Ricardo Paniagua

5

1 reference

6 February 2018

Mar Royuela

6

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 April 2004

1 reference

6 February 2018

number of pages

9

1 reference

inferred from page(s)

published in

Cancer

1 reference

6 February 2018

volume

100

1 reference

6 February 2018

issue

7

1 reference

6 February 2018

page(s)

1388-1396

1 reference

6 February 2018

Glial cell-specific mechanisms of TGF-beta 1 induction by IL-1 in cerebral cortex

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

Molecular analysis of constitutive IL-1alpha gene expression in human melanoma cells: autocrine stimulation through NF-kappaB activation by endogenous IL-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

Interleukin-1--a major pleiotropic cytokine in tumor-host interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

Asymptomatic inflammation and/or infection in benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

Interleukin-1 beta, but not IL-1 alpha, mediates nerve growth factor secretion from rat astrocytes via type I IL-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

Binding and internalization of interleukin 1 by T cells. Direct evidence for high- and low-affinity classes of interleukin 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

Autocrine and paracrine regulation by cytokines and growth factors in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

Interleukin-6: a candidate mediator of human prostate cancer morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

Regulation of transcription of the intracellular interleukin-1 receptor antagonist gene by AP-1 in mouse carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

The balance between IL-1 and IL-1Ra in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

Structure-function relationship in the IL-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

7 January 2021

Interleukin-1 family expression in human breast cancer: interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

7 January 2021

Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

7 January 2021

Neuroendocrine and immune mediators in prostate cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

7 January 2021

Relationship of the interleukin-1 system with neuroendocrine and exocrine markers in human colon cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

7 January 2021

Biologically active, alternatively processed interleukin-1 beta in psoriatic scales

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

7 January 2021

Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

7 January 2021

Characterisation of inflammatory cells in benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

7 January 2021

Analysis of mutations in the putative nuclear localization sequence of interleukin-1β

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

7 January 2021

Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

7 January 2021

Receptor-mediated endocytosis and nuclear transport of human interleukin 1 alpha

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

7 January 2021

Cellular senescence in the pathogenesis of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

7 January 2021

Intra-tumoral interleukin-6 down-regulation system and genetic mutations of tumor suppressor genes in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

7 January 2021

Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

7 January 2021

Cytokines in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

7 January 2021

Pro-apoptotic tumor necrosis factor-alpha transduction pathway in normal prostate, benign prostatic hyperplasia and prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

7 January 2021

Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20142

7 January 2021

Identifiers

DOI

10.1002/CNCR.20142

1 reference

6 February 2018

1 reference

6 February 2018